FutureChem Co Ltd
Company Profile
Business description
FutureChem Co Ltd is a radiopharmaceuticals company engaged in manufacturing related precursors chemicals, automatic synthesizer, and synthesis reagents and develops & commercializes new traces with research and development. It offers radiopharmaceuticals for diagnosing cancers, and Alzheimer's diseases; and automation modules and disposable goods, such as disposable cassettes, reagent kits, and radio-caps. It also provides peptide-based radiopharmaceuticals for radio-metal chelation and click reaction; linkers for bio-conjugation using copper-free/mediated click reaction. In addition, the company is involved in the research and development of radioisotope labeling technology; and automation devices. Further, it offers amino acids and reagents for peptides; and ionic liquids.
Contact
59, Seongsuil-ro
3rd Floor, B-dong, Pyeonghwa Building
Seoul04782
KORT: +82 24973114
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
87
Stocks News & Analysis
stocks
Is this still an ASX share to own forever?
stocks
After earnings, is Nvidia stock a buy, a sell, or fairly valued?
stocks
Short-term pain for long-term gain for undervalued ASX share
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,091.40 | 51.20 | 0.57% |
CAC 40 | 7,688.52 | 31.19 | -0.40% |
DAX 40 | 23,680.88 | 86.08 | 0.36% |
Dow JONES (US) | 45,271.23 | 24.58 | -0.05% |
FTSE 100 | 9,182.17 | 4.18 | 0.05% |
HKSE | 25,058.51 | 284.92 | -1.12% |
NASDAQ | 21,497.73 | 218.10 | 1.02% |
Nikkei 225 | 42,580.27 | 641.38 | 1.53% |
NZX 50 Index | 13,133.20 | 58.39 | 0.45% |
S&P 500 | 6,448.26 | 32.72 | 0.51% |
S&P/ASX 200 | 8,826.50 | 59.20 | 0.68% |
SSE Composite Index | 3,765.88 | 47.68 | -1.25% |